Table of Contents Author Guidelines Submit a Manuscript
Journal of Ophthalmology
Volume 2014, Article ID 502174, 6 pages
http://dx.doi.org/10.1155/2014/502174
Clinical Study

Aqueous Interleukin-6 Levels Are Superior to Vascular Endothelial Growth Factor in Predicting Therapeutic Response to Bevacizumab in Age-Related Macular Degeneration

Department of Ophthalmology, University of Florida College of Medicine, 580 West 8th Street, Tower 2, Jacksonville, FL 32209, USA

Received 24 April 2014; Revised 3 June 2014; Accepted 9 June 2014; Published 10 July 2014

Academic Editor: Siamak Ansari-Shahrezaei

Copyright © 2014 Kakarla V. Chalam et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Kakarla V. Chalam, Sandeep Grover, Kumar Sambhav, Sankarathi Balaiya, and Ravi K. Murthy, “Aqueous Interleukin-6 Levels Are Superior to Vascular Endothelial Growth Factor in Predicting Therapeutic Response to Bevacizumab in Age-Related Macular Degeneration,” Journal of Ophthalmology, vol. 2014, Article ID 502174, 6 pages, 2014. https://doi.org/10.1155/2014/502174.